(MYOK) |
| 0 (0%) 04-14 05:01 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 0.97 |
| Resistance 1: | 0.83 |
| Pivot price: | 0.69 |
| Support 1: | 0.69 |
| Support 2: | 0.61 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Thu, 20 Nov 2025
Kia showcases new EV4 at contemporary Korean bathhouse in Dezeen video - Dezeen
Thu, 24 Apr 2025
MYOK Stock Price, News & Analysis - Stock Titan
Mon, 05 Feb 2024
Physical Exercise-Induced Myokines and Muscle-Adipose Tissue Crosstalk: A Review of Current Knowledge and the Implications for Health and Metabolic Diseases - Frontiers
Sat, 24 Oct 2020
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm – STND, MYOK, EIDX, WTRE - ChartMill
Wed, 07 Oct 2020
Here's Why Bristol Myers Offered MyoKardia $13.1 Billion - The Motley Fool
Tue, 06 Oct 2020
BMS acquires MyoKardia, maker of drugs for cardiovascular disease, for $13.1B - MedCity News
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
